Bicycle is a transatlantic company headquartered in the vibrant life science cluster of Cambridge U.K., with many key functions and members of our leadership team located in our offices in the biotech hub of Boston, Mass, U.S.A.
U.K. Location:
Bicycle Therapeutics, plc
Blocks A & B Portway Building
Granta Park
Great Abington
Cambridge CB21 6GS
United Kingdom
+44 1223 261503
U.S. Location:
Bicycle Therapeutics, Inc.
4 Hartwell Place
Lexington, MA 02421
Bicycle Therapeutics is incorporated in England and Wales.
Bicycle Therapeutics was founded in 2009.
Bicycle Therapeutics is traded on the Nasdaq Global Select Market under the ticker “BCYC.”
Bicycle Therapeutics’ initial public offering was on May 22, 2019.
Bicycle Therapeutics’ fiscal year ends on December 31.
PricewaterhouseCoopers LLP.
088786108
Bicycle Therapeutics’ ADSs can be purchased by contacting a securities broker of your choice.
Bicycle Therapeutics does not currently offer a direct share purchase plan.
Bicycle Therapeutics does not currently pay dividends in its ADSs and it does not have a dividend reinvestment program.
Bicycle Therapeutics’ transfer agent is Computershare. Please see contact information below:
T +44 (0370) 703 0031
Email: webcorres@computershare.co.uk
The Pavilions, Bridgwater Road, Bristol BS13 8AE, United Kingdom
www.computershare.com
The depositary for Bicycle Therapeutics’ ADSs is Citibank N.A. Please see contact information below:
Tel: 1-877-CITI-ADR (toll free)
Tel: 1-781-575-4555 (outside US)
Fax 1-201-324-3284
www.citi.com/dr
E-mail at: Citibank@shareholders-online.com
If you hold ordinary shares in your name, you must contact Bicycle Therapeutics’ transfer agent, Computershare. If you hold ADSs or ordinary shares in street name, you must contact your broker to update your address.
Quarterly & Annual reports and other investor materials are available under Filings in the Investors section of Bicycle Therapeutics’ corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please visit the Investors section of Bicycle Therapeutics’ corporate website and choose the Email Alerts link to be added to the Bicycle Therapeutics distribution list.
For media inquiries, please contact:
Media Relations
Bicycle Therapeutics
media@bicycletx.com
Investor Relations
Bicycle Therapeutics
IR@bicycletx.com
Email Alerts
By signing up to our mailing list, you agree to our Privacy Policy